Arakis
London
About Arakis
Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company's research capability specializes in the cytokine and receptor mediated mechanisms of disease. The company identifies, develops, and commercializes product opportunities based upon new clinical uses for known drugs or known drug templates, as well as termed performance enhanced medicines.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $80.7M
- Funding stage: M&A
- Last round: Series C (Sep 2004)
- Website: arakis.com
- Phone: +44 20 7691 2081
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Canonical: https://fsome.com/organization/arakis-1740176 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.